What Is The Estimated Industry Size Of Oral Antidiabetic Drugs Market?
The market size for oral antidiabetic medication has seen powerful growth in the past few years. The value is projected to rise from $62.25 billion in 2024 to $66.73 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. The past growth can be credited to the heightened occurrence of diabetes, better knowledge about managing the disease, an increase in the elderly population, expanded accessibility of advanced oral antidiabetic drugs, and developments in healthcare infrastructure.
The market size for oral antidiabetic drugs is anticipated to experience robust growth in the upcoming years, reaching $86.92 billion in 2029 with a compound annual growth rate (CAGR) of 6.8%. The escalation for the projected period is tied to factors like the increasing utilization of new oral antidiabetic therapies, significant investments in diabetes research and development, growing demand for affordable diabetes management solutions, increasing instances of type 2 diabetes worldwide, and a heightened emphasis on personalized medicine for diabetes treatment. Anticipated trends for the forecast period consist of the progression in drug delivery technologies, pioneering efforts in composite therapies, adoption of digital health instruments for diabetes regulation, fabrication of safer and more competent oral antidiabetic drugs, and advancements in tailored treatment methodologies.
